English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/20329
Título

Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies

AutorSegura, Mireia; Ortuño, Jordi; Farré-Albaladejo, Magi; Pacifici, Roberta; Pichini, Simona; Joglar Tamargo, Jesús; Segura, Jordi; Torre, Rafael de la
Palabras claveHigh-Performance Liquid chromatography (HPLC)
Paroxetine
Pharmacokinetic properties
Plasma concentrations
Fecha de publicación22-may-2003
EditorWiley-Blackwell
CitaciónRapid Communications in Mass Spectrometry 17(13): 1455-1461 (2003)
ResumenA high-performance liquid chromatography (HPLC) method with tandem mass spectrometric detection is described for the determination of paroxetine, an antidepressant drug, and its metabolite (3S,4R)-4-(4-fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine (HM paroxetine) in human plasma. Plasma samples were hydrolysed with hydrochloric acid and then analytes were extracted with ethyl acetate at alkaline pH. Extracts were analysed by HPLC coupled to an atmospheric pressure ionisation-electrospray (ESI) interface and an ion trap mass spectrometer. Chromatography was performed on a reversed-phase column using acetonitrile/0.02% formic acid (66:34, v/v) as a mobile phase. The mass spectrometer was operated in the multiple reaction monitoring mode. The method was validated over concentration ranges of 0.75-100 g/L and 5-100 g/L for paroxetine and HM paroxetine, respectively. Mean recoveries of 77% for paroxetine and 76% for HM paroxetine were found, with precision always better than 15%. The limits of detection and quantification were 0.20 and 0.70 g/L for paroxetine, and 0.70 and 2.20 g/L for its metabolite. The method was applied to the analysis of plasma samples obtained from nine healthy male volunteers administered with a single oral dose of 20 mg paroxetine. After the 20-mg dose, the mean peak plasma concentration was 8.60 g/L for paroxetine and 92.40 g/L for HM paroxetine showing a tenfold ratio between the metabolite and the parent drug along the entire time-concentration curve.
Descripción7 pages, 4 figures, 3 tables.-- PMID: 12820211 [PubMed].-- Printed version published Jul, 22, 2003.
Versión del editorhttp://dx.doi.org/10.1002/rcm.1067
URIhttp://hdl.handle.net/10261/20329
DOI10.1002/rcm.1067
ISSN0951-4198 (Print)
1097-0231 (Online)
Aparece en las colecciones: (IQAC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Segura_Mireia_et_al.pdf155,91 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.